Stocks News

LAST PRICE
994.4100
TODAY'S CHANGE (%)
Trending Down-8.5400 (-0.8515%)

Bid / Lots
993.5400/ 1
Ask / Lots
994.9000/ 4
Open / Previous Close
998.4500 / 1,002.9500
Day Range
Low 992.2200
High 998.4500
52 Week Range
Low 684.8050
High 1,016.0000
Volume
47,505
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Yesterday
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN, from 23 hours ago by Dow Jones
  23 hours ago by Dow Jones
  Companies Mentioned: REGN
  
  NEW YORK, NY / ACCESSWIRE / June 9, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Regeneron Pharmaceuticals, Inc. ("Regeneron" or the "Company") (NASDAQ:REGN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
- The Schall Law Firm Has Begun An Investigation Into Claims Against Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) And Encourages Investors Who Have Suffered Losses To Contact Them, from 11:05AM ET on Sunday Jun 09, 2024 by Dow Jones
  11:05AM ET on Sunday Jun 09, 2024 by Dow Jones
  Companies Mentioned: REGN
  
  LOS ANGELES, CA / ACCESSWIRE / June 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Regeneron Pharmaceuticals, Inc. ("Regeneron" or "the Company") (NASDAQ:REGN) for violations of the securities laws.
Jun 8, 2024
- The Schall Law Firm Has Initiated A Probe Into Allegations Against Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) And Urges Investors Who Have Experienced Losses To Reach Out, from 11:04AM ET on Saturday Jun 08, 2024 by Dow Jones
  11:04AM ET on Saturday Jun 08, 2024 by Dow Jones
  Companies Mentioned: REGN
  
  LOS ANGELES, CA / ACCESSWIRE / June 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Regeneron Pharmaceuticals, Inc. ("Regeneron" or "the Company") (NASDAQ:REGN) for violations of the securities laws.
Jun 7, 2024
- The Schall Law Firm Announces An Investigation Into Claims Against Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) And Encourages Investors Who Have Suffered Losses To Get In Touch, from 3:00PM ET on Friday Jun 07, 2024 by Dow Jones
  3:00PM ET on Friday Jun 07, 2024 by Dow Jones
  Companies Mentioned: REGN
  
  LOS ANGELES, CA / ACCESSWIRE / June 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Regeneron Pharmaceuticals, Inc. ("Regeneron" or "the Company") (NASDAQ:REGN) for violations of the securities laws.
- Regeneron Pharmaceuticals, Inc. (REGN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings, from 11:01AM ET on Friday Jun 07, 2024 by Dow Jones
  11:01AM ET on Friday Jun 07, 2024 by Dow Jones
  Companies Mentioned: REGN
  
  NEW YORK, NY / ACCESSWIRE / June 7, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Regeneron Pharmaceuticals, Inc. ("Regeneron" or "the Company") (NASDAQ:REGN). Investors who purchased Regeneron securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/REGN.

Today
- Moderna, Inc. (MRNA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings, from 27 minutes ago by Accesswire
  27 minutes ago by Accesswire
  Companies Mentioned: MRNA
- Moderna, Inc. (MRNA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings, from 1 hour ago by Business Wire
  1 hour ago by Business Wire
  Companies Mentioned: MRNA
- Moderna's Combined Influenza, COVID-19 Shot Elicits 'Higher Immune Response' Versus Others, Drugmaker Says, from 2 hours ago by MT Newswires
  2 hours ago by MT Newswires
  Companies Mentioned: MRNA
- Exchange-Traded Funds, Equity Futures Retreat Pre-Bell Monday Ahead of Key Economic Data, FOMC Announcement, from 3 hours ago by MT Newswires
  3 hours ago by MT Newswires
  Companies Mentioned: STLA, GLD, FAS, FAZ, IBB, IGM, IGV, SOXX, IVV, IWM, IYE, IYH, IYJ, IYK, IYW, LUV, QQQ, SPY, VDC, VHT, VIS, XLE, XLF, XLI, XLK, XLP, XLV, XLY, XSD, RTH, USO, SLV, MRNA, XRT, CRWD, BITF, EXI, NE, BITO, DO, UNG, EEM
- IQVIA Institute: Innovative Therapies and Strong Pipeline to Combat Rise in Cancer Diagnoses, from 3 hours ago by Business Wire
  3 hours ago by Business Wire
  Companies Mentioned: IQV
- Moderna Says Combination Vaccine Shows Higher Immune Response Against Flu, Covid-19 in Phase 3 Trial, from 4 hours ago by MT Newswires
  4 hours ago by MT Newswires
  Companies Mentioned: MRNA
- Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19, from 4 hours ago by Accesswire
  4 hours ago by Accesswire
  Companies Mentioned: MRNA
- Biogen, Eisai Say Alzheimer's Maintenance Treatment Application Accepted by US FDA, from 7 hours ago by MT Newswires
  7 hours ago by MT Newswires
  Companies Mentioned: BIIB
Yesterday
- Moderna, Inc. (MRNA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings, from 11:02AM ET on Sunday Jun 09, 2024 by Accesswire
  11:02AM ET on Sunday Jun 09, 2024 by Accesswire
  Companies Mentioned: MRNA
Jun 7, 2024
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA, from 3:03PM ET on Friday Jun 07, 2024 by PR Newswire
  3:03PM ET on Friday Jun 07, 2024 by PR Newswire
  Companies Mentioned: MRNA

Regeneron Pharmaceuticals Inc
NASDAQ:REGNUnited States

Search Criteria

Yesterday

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN, from 23 hours ago by Dow Jones

The Schall Law Firm Has Begun An Investigation Into Claims Against Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) And Encourages Investors Who Have Suffered Losses To Contact Them, from 11:05AM ET on Sunday Jun 09, 2024 by Dow Jones

Jun 8, 2024

The Schall Law Firm Has Initiated A Probe Into Allegations Against Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) And Urges Investors Who Have Experienced Losses To Reach Out, from 11:04AM ET on Saturday Jun 08, 2024 by Dow Jones

Jun 7, 2024

The Schall Law Firm Announces An Investigation Into Claims Against Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) And Encourages Investors Who Have Suffered Losses To Get In Touch, from 3:00PM ET on Friday Jun 07, 2024 by Dow Jones

Regeneron Pharmaceuticals, Inc. (REGN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings, from 11:01AM ET on Friday Jun 07, 2024 by Dow Jones

Peers Headlines

Today

Moderna, Inc. (MRNA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings, from 27 minutes ago by Accesswire

Moderna, Inc. (MRNA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings, from 1 hour ago by Business Wire

Moderna's Combined Influenza, COVID-19 Shot Elicits 'Higher Immune Response' Versus Others, Drugmaker Says, from 2 hours ago by MT Newswires

Exchange-Traded Funds, Equity Futures Retreat Pre-Bell Monday Ahead of Key Economic Data, FOMC Announcement, from 3 hours ago by MT Newswires

IQVIA Institute: Innovative Therapies and Strong Pipeline to Combat Rise in Cancer Diagnoses, from 3 hours ago by Business Wire

Moderna Says Combination Vaccine Shows Higher Immune Response Against Flu, Covid-19 in Phase 3 Trial, from 4 hours ago by MT Newswires

Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19, from 4 hours ago by Accesswire

Biogen, Eisai Say Alzheimer's Maintenance Treatment Application Accepted by US FDA, from 7 hours ago by MT Newswires

Yesterday

Moderna, Inc. (MRNA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings, from 11:02AM ET on Sunday Jun 09, 2024 by Accesswire

Jun 7, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA, from 3:03PM ET on Friday Jun 07, 2024 by PR Newswire